Classification performance of the 2023 ACR/EULAR antiphospholipid syndrome criteria: a systematic review and meta-analysis.
The 2023 ACR/EULAR APS classification criteria exhibit consistently excellent specificity but reduced and phenotype-dependent sensitivity, which reinforces the intended role of the criteria for classification rather than clinical diagnosis and highlight important limitations in specific APS subgroups.